医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Single-cell transcriptomic dissection of the cellular and molecular events underlying the triclosan-induced liver fibrosis in mice

摘要Background:Triclosan[5-chloro-2-(2,4-dichlorophenoxy)phenol,TCS],a common antimicrobial additive in many personal care and health care products,is frequently detected in human blood and urine.Therefore,it has been considered an emerging and potentially toxic pollutant in recent years.Long-term exposure to TCS has been suggested to exert endocrine disruption effects,and promote liver fibrogenesis and tumorigenesis.This study was aimed at clarifying the underlying cellular and molecular mechanisms of hepatotoxicity effect of TCS at the initiation stage.Methods:C57BL/6 mice were exposed to different dosages of TCS for 2 weeks and the organ toxicity was evaluated by various measurements including complete blood count,histological analysis and TCS quantification.Single cell RNA sequencing(scRNA-seq)was then carried out on TCS-or mock-treated mice livers to delineate the TCS-induced hepatotoxicity.The acquired single-cell transcriptomic data were analyzed from different aspects including differential gene expression,transcription factor(TF)regulatory network,pseudotime trajectory,and cellular communication,to systematically dissect the cellular and molecular events after TCS exposure.To verify the TCS-induced liver fibrosis,the expression levels of key fibrogenic proteins were examined by Western blotting,immunofluorescence,Masson's trichrome and Sirius red stainings.In addition,normal hepatocyte cell MIHA and hepatic stellate cell LX-2 were used as in vitro cell models to experimentally validate the effects of TCS by immunological,proteomic and metabolomic technologies.Results:We established a relatively short term TCS exposure murine model and found the TCS mainly accumulated in the liver.The scRNA-seq performed on the livers of the TCS-treated and control groups profiled the gene expressions of>76,000 cells belonging to 13 major cell types.Among these types,hepatocytes and hepatic stellate cells(HSCs)were significantly increased in TCS-treated group.We found that TCS promoted fibrosis-associated proliferation of hepatocytes,in which Gata2 and Mef2c are the key driving TFs.Our data also suggested that TCS induced the proliferation and activation of HSCs,which was experimentally verified in both liver tissue and cell model.In addition,other changes including the dysfunction and capillarization of endothelial cells,an increase of fibrotic characteristics in B plasma cells,and M2 phenotype-skewing of macrophage cells,were also deduced from the scRNA-seq analysis,and these changes are likely to contribute to the progression of liver fibrosis.Lastly,the key differential ligand-receptor pairs involved in cellular communications were identified and we confirmed the role of GAS6_AXL interaction-mediated cellular communication in promoting liver fibrosis.Conclusions:TCS modulates the cellular activities and fates of several specific cell types(including hepatocytes,HSCs,endothelial cells,B cells,Kupffer cells and liver capsular macrophages)in the liver,and regulates the ligand-receptor interactions between these cells,thereby promoting the proliferation and activation of HSCs,leading to liver fibrosis.Overall,we provide the first comprehensive single-cell atlas of mice livers in response to TCS and delineate the key cellular and molecular processes involved in TCS-induced hepatotoxicity and fibrosis.

更多
广告
作者 Yun-Meng Bai [1] Fan Yang [2] Piao Luo [3] Lu-Lin Xie [3] Jun-Hui Chen [1] Yu-Dong Guan [3] Hong-Chao Zhou [3] Teng-Fei Xu [3] Hui-Wen Hao [3] Bing Chen [2] Jia-Hui Zhao [2] Cai-Ling Liang [3] Ling-Yun Da [4] Qing-Shan Geng [4] Ji-Gang Wang [5] 学术成果认领
作者单位 Department of Nephrology,Shenzhen Key Laboratory of Kidney Diseases,and Shenzhen Clinical Research Centre for Geriatrics,Shenzhen People's Hospital,the First Affiliated Hospital,Southern University of Science and Technology,Shenzhen 518020,China [1] Department of Urology,Shenzhen People's Hospital,the First Affiliated Hospital,Southern University Science and Technology,the Second Clinical Medical College,Jinan University,Shenzhen 518020,China;Integrated Chinese and Western Medicine Postdoctoral Research Station,Jinan University,Guangzhou 510632,China [2] Department of Urology,Shenzhen People's Hospital,the First Affiliated Hospital,Southern University Science and Technology,the Second Clinical Medical College,Jinan University,Shenzhen 518020,China [3] Department of Nephrology,Shenzhen Key Laboratory of Kidney Diseases,and Shenzhen Clinical Research Centre for Geriatrics,Shenzhen People's Hospital,the First Affiliated Hospital,Southern University of Science and Technology,Shenzhen 518020,China;Department of Urology,Shenzhen People's Hospital,the First Affiliated Hospital,Southern University Science and Technology,the Second Clinical Medical College,Jinan University,Shenzhen 518020,China [4] Department of Nephrology,Shenzhen Key Laboratory of Kidney Diseases,and Shenzhen Clinical Research Centre for Geriatrics,Shenzhen People's Hospital,the First Affiliated Hospital,Southern University of Science and Technology,Shenzhen 518020,China;Department of Urology,Shenzhen People's Hospital,the First Affiliated Hospital,Southern University Science and Technology,the Second Clinical Medical College,Jinan University,Shenzhen 518020,China;Artemisinin Research Center,and Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;Guangdong Provincial Key Laboratory of New Drug Screening,School of Pharmaceutical Sciences,Southern Medical University,Guangzhou 510515,China;Center for Reproductive Medicine,Dongguan Maternal and Child Health Care Hospital,Southern Medical University,Dongguan 523125,Guangdong,China [5]
栏目名称
DOI 10.1186/s40779-023-00441-3
发布时间 2023-11-17(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览10
  • 下载1
军事医学研究(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷